T he purpose of bone augmentation procedures is reconstruction of the resorbed edentulous ridges to allow the placement of endosseous dental implants. Sinus lifting is the most common and the most documented application of this concept. 1, 2 However, even though the reliability of this technique is widely established, [3] [4] [5] the procedure remains very delicate. 6 In fact, secondary parameters may occur and jeopardize the treatment evolution. They are divided into 3 categories: bacterial contamination, delayed healing, and mechanical stress.
Infectious complications are dramatic events, but their frequency remains unknown, due to a lack of reference studies in the literature. 7 They might occur as frequently as 2% to 7%, often leading to the removal of the grafted tissue, thus enhancing the risk for necrotic and infectious sites to develop. To prevent this risk, many antibiotics have been tested, by systemic 8 or local 9 -20 administration: penicillins, tetracyclines, and macrolides. However, it was always difficult to emphasize the true effect of these antibiotics on bone graft healing. Moreover, the tested antibiotics offer quite a wide spectrum, whereas the possible bone infections would more logically originate from anaerobic bacteria, which are particularly sensitive to metronidazole. 21, 22 To our knowledge, among the international english literature, metronidazole has yet never been experimented for this procedure. 23, 24 Metronidazole is an antibiotic which belongs to the nitro-5-imidazole group. Administered orally alone (Flagyl) or combined with macrolides (such as spiramycin in Birodogyl), it has been in use for a long time [25] [26] [27] [28] to treat oral infections in general 29 and periodontal infections more specifically, using a systemic 30 -34 or topical application (with gels of various concentrations). [35] [36] [37] [38] [39] [40] It is often coupled with amoxicillin by systemic administration. [41] [42] [43] A small quantity of metronidazole may also be used locally in a pure form (injectable solution), mixed with the graft, at the time of surgery, to limit systematic perioperative contamination by anaerobic bacteria.
According to our experience, the analysis of tomodensitometric controls 3 months after sinus grafts (using allogenous or xenogenous bone granules) demonstrates a quite systematic image: the grafted bone still seems to be non homogeneous (Fig. 1 ). This irregular appearance does not contraindicate implant placement. In addition, the success rate of implants placed in the subsinus area is very similar to that of implants placed in other regions. 1, 2 The heterogeneity is thus considered as "normal." Hence, we have anticipated that these lacks of homogeneity could possibly be related to bacterial contamination during the surgical procedure.
The aim of this study was to characterize statistically the nonhomogeneities observed at 1, 2, or 3 months postsurgery within the allogenous sinus grafts and assess the possible effect of a 0.5% metronidazole sterile solution incorporated in the sinus bone graft.
MATERIALS AND METHODS

Patient Selection
This clinical study was conducted on 72 patients treated with either single or bilateral sinus-lifts: a total of 94 sinus elevations were performed between January 2001 and December 2003 using freeze-dried bone allograft (FDBA, Phoenix, TBF, Mions, France), with or without metronidazole (Table 1 ). The study was conducted according to the Helsinki Declaration of 1983. The patients were informed on the aim and design of the study, and their written consent was obtained.
Patients with immune disorders, unstable diabetes mellitus, ongoing chemo-or radiotherapy, or with a history of drug abuse were excluded. The inclusion criteria were the following: a thrombocyte blood concentration within the normal range, and no history of maxillary sinus inflammation. Clinical examination and preoperative radiographs showed a severe atrophy of the maxilla.
Surgical Procedure
Surgery was performed under local anesthesia. Access to the lateral maxillary wall was achieved using a soft tissue crestal incision followed by anterior and posterior releasing buccal incisions. A bone window of approximately 15 to 20 mm 2 was outlined using a round bur under constant saline irrigation. It was then moved medial and left attached to the sinus membrane. After careful elevation of the Schneiderian membrane avoiding any perforation, the sinus was filled with a grafting biomaterial.
One to 2 g of Phoenix (TBF, Mions, France) containing FDBA granules (200 -800 m diameter) were instilled to augment the sinus floor in 94 cases. In 12 cases, the sinus was filled with FDBA only (control group). In the 82 other cases, metronidazole was added to the bone graft particles (test group). For 2 patients, bilateral sinuslifts were performed with unilateral use of metronidazole. This specific situation had not been planned at the beginning of the study, but the volume of the grafting material prepared with metronidazole was not sufficient for the two sinuses. For these 2 patients, 2 postoperative computerized tomography-scans (CT x-ray scanner) were performed respectively at 10 days and 2 months.
Five milliliters of a 0.5% sterile metronidazole solution (25 mg) was used for each treated sinus-lift as follows:
Three milliliters for sinus rinse after membrane elevation; Two milliliters to hydrate the allogenous bone (mixed with 10% of harvested autogenous bone), i.e., only 10 mg of metronidazole (equivalent to 1/20 of a common 200 mg oral tablet). All the patients received 60 mg of prednisolone just before surgery, and 2 g of amoxicillin per day (systemic oral administration) during 6 days. Paracetamol was also prescribed when needed.
This study is multicentric: 3 different surgeons participated to this protocol after evaluation of their surgical technique. All applied the same protocol, and were controlled and advised by the same anesthetist, to guarantee the homogeneity of results. Finally, 50 patients out of 72 were treated by the same surgeon.
Long-Term Postoperative Oedema
Often following sinus elevations, 1 or several inflammatory events associated with facial oedema may occur spontaneously between the first and the sixth month postsurgery. They are more often isolated, but sometimes repetitive. They are generally stopped with conventional anti-inflammatory corticoids (such as prednisolone) and antibiotics (such as amoxicillin).
In this study, we accounted the number of treated patients having undergone these late inflammatory events, depending on the use of metronidazole. Evaluation of facial oedema is subjective. It combines an obvious skin swelling (1-5 mm) compared with the treated side, and sometimes pain. For the present evaluation, we only considered the events which were sufficiently severe to render the patient anxious and visit his physician.
Analysis of the CT-Scan Images
This study analyses a total of 83 scans, originating from 72 patients.
The surgeons performed 94 consecutive sinus-lifts: 50 unilateral sinus-lifts (42 with metronidazole, 8 without metronidazole) and 22 bilateral sinuslifts (19 with metronidazole, 1 without metronidazole, 2 with a unilateral use of metronidazole). Patients were all subjected to at least 1 preoperative CT-scan, and 1 control scan at either 1, 2, or 3 months postsurgery (the control scan was also used as a preliminary scan before implant placement). For 11 patients, 2 postsurgical CTscans were performed respectively at 10 days and 2 months. This protocol was established according to patient consent, and after they had been informed of the possible stochastic risks in relation to a repeated x-ray exposure. Most of the scans were performed at 2 or 3 months postsurgery (Tables 1 and 2 ).
The Hounsfield units (HU) allow to evaluate the radiographic density of the different tissues on a CT-scan. 44 They represent density values of a tissue compared with that of air, water, and dense bone, for which an arbitrary scale is established, either respectively, Ϫ1000 HU, 0 HU, and ϩ1000 HU. The analysis of the sinus grafts using this scale only allows to obtain some information on their radiopacity. With allogenous or xenogenous bone grafts, mainly composed of a mineral- The scattering of the different densities is obviously wider without metronidazole than within the grafts treated with metronidazole. This scattering pattern may be considered as a lack of graft homogeneity.
On the scans performed at 10 days postsurgery, the high differences of homogeneity observed are due to the air bubbles, which have occurred within some areas of the graft.
ized matrix, measurement of HU provides no information on the quality of the bone graft maturation, and hence offers no interest. The aim of this study was to determine, using an arbitrary gray scale functioning according to the HU principle, the degree of radiographic homogeneity of the grafts. This computer unit is called the Arbitrary Densitometric Unit (ADU). All the coronal reconstructed images of the CT-scans performed at 10 days, 1 month, 2 months, or 3 months were processed using the homemade software (D-TEPv3.5). This software determines a gray scale for each scan according to the same principle as that of the HU: 0 ADU for air, 50 ADU for water, 100 ADU for dense bone. Then, each reconstructed coronal image of the graft is treated separately by performing an analysis circle of 8 mm diameter in the center of the graft. For each analyzed surface, the calculation software for differential density provides the percentage obtained for each of the following density groups: 0 to 50 ADU, 50 to 65 ADU, 65 to 80 ADU, more than 80 ADU. The results expressed in percents are rounded up to the closest (Table 2) .
Density scattering gives some information on the homogeneity or non homogeneity of the bone graft. A graft will be arbitrarily considered as:
Nonhomogeneous when at least 60% of its surface is represented equally in 3 different density groups (i.e., at least 20% per group). Significantly nonhomogeneous when at least 90% of its surface is represented equally in 3 different density groups (i.e., at least 30% per group). Homogeneous when more than 60% of its surface is represented in only 1 specific group. Significantly homogeneous when more than 80% of its surface is represented in only 1 specific group.
RESULTS
In this series of 94 patients, sinuslifts were performed by experienced clinicians recruited according to a strict checklist. No severe infectious complications were observed, with or without metronidazole.
The 12 grafts performed without metronidazole show significant nonhomogeneous areas following 1, 2, or 3 months. Moreover, when a CTscan is performed during the first postoperative days (at 10 days), the presence of bubble-like lacunae within the graft is observed (Fig. 2) . The densitometric analysis using ADU confirms a gap in the graft homogeneity. When a second control CT-scan is performed at 2 months postsurgery, the air bubbles observed at 10 days seem super-imposable with the areas showing an obvious significant nonhomogeneity.
The tomodensitometric aspects of all grafts treated with metronidazole in this series are absolutely identical: they show a high degree of homogeneity. Sixty-three cases (76,8%) are homogeneous, and 19 cases (23,2%) are significantly homogeneous. The time at which the control scan is performed (10 days, 1, 2, or 3 months) does not seem to influence significantly the degree of homogeneity assessed.
These results are perfectly obvious in the case of double sinus-lifts with unilateral use of metronidazole, followed by postoperative CT-scans performed at 10 days and 2 months (Fig. 3 and Table 3 ).
Moreover, the compact and regular radiographic aspect of a graft with metronidazole allows practitioners to perform sinus implantation on the 90th day (Figs. 4 and 5) .
In the control group, inflammatory events associated with facial oedema were observed in 25% of the cases, which corresponds to the average generally observed. In the test group, no such event occurred for the 82 sinus-lifts treated with metronidazole (Table 4) .
It is not possible to demonstrate significant differences of homogeneity between the 3 different clinicians involved in this study.
DISCUSSION
The oral cavity contains a significant amount of anaerobic flora. The role of bacteria in oral infectious pathologies is already well established. In a healthy gingiva, 18% to 44% of anaerobic bacteria can be found (Gramϩ and GramϪ). Such levels increase considerably with the presence of slight inflammation, and in acute or 45 Anaerobic bacteria may also be systematically found in periapical abscesses and associated sinusitis. 46 It was also demonstrated that anaerobic bacteria play a basic role in periodontitis and periimplantitis. 47 The risk of infection associated with this flora is thus obvious. Nevertheless, even following a strict periodontal treatment, it is yet impossible to perform surgery on patients with a perfectly healthy mouth. So, in spite of a strict surgical asepsis, perioperative bacterial contamination by anaerobic bacteria seems unavoidable. But how does this contamination influence the healing of sinus grafts?
The fortuitous discovery of bubble-like lacunae within the graft allows to suggest a new realistic hypothesis concerning infectious risk during sinus grafting: the "septic theory." The presence of air bubbles within the graft confirms anaerobic bacterial activity. Indeed, such vacuoles cannot be due to a lack of condensation in the graft material: given their size and shape, it must be the result of air bubbles formation within the graft, and only anaerobic bacteria may be involved. This "septic theory" suggests that the grafted bone contamination by anaerobic bacteria would be responsible for healing problems, and therefore, any protocol able to stop this silent infection should result in a dramatic improvement for graft quality.
To validate this approach, histological analyses are difficult to perform because these processes occur during the very first weeks postsurgery. And, it seems impossible to harvest coherent bone fragments within the grafts before 3 months, even with highly performing materials such as FDBAs. The use of the ADU seems to be a clever approach to demonstrate these events within the grafts. The ADU replaces favorably the HU, because this computerized unit allows us to analyze, based on the same methodology, coronal reconstructed images originating from different types of spiral CT-scans, and even cone beam CT-scans. ADUs standardization is performed separately for each studied scan, to avoid any bias related to the type of imagery device employed. Moreover, in this study, we wanted to analyze the relationships between the different densities, rather than the densities themselves: the calculation interfaces of the HU developed for radiologists are not adapted for this use at all.
Moreover, the anaerobic contamination process is probably systematic for all types of bone grafts. Nevertheless, this can only be clearly demonstrated on this specific type of sinus graft, due to the large volume of these grafts which are composed of biomaterials (offering a very high mineral phase), very homogeneous, and therefore very radiopaque: any change in their homogeneity is thus easily quantifiable on the scan, which would not be the case for an autogenous graft (iliac, calvarial, chin . . .).
Finally, although it cannot replace the efficiency of strict surgical asepsis associated with antiseptic coverage, the local use of a very small quantity of metronidazole may improve the remodeling process of the graft by avoiding initial infectious development and associated inflammatory reactions. It may thus help to reduce the risk of infected bone formation, and possible necrosis.
CONCLUSION
This new approach to prevent perioperative anaerobic contamination appears simple and rational. To this day, the antibiotic treatments prescribed during sinus-lift procedures either pre-or postsurgically, by local or systemic administration, were mainly aerobic antibacterial therapies. The local use of a very small quantity of metronidazole (equivalent to only 1/20 of a common 200 mg oral tablet), to protect the graft material from this anaerobic contamination, may lead to a more secure approach when performing sinus-lifts and an improved graft quality. Moreover, the quantity of metronidazole needed to obtain the protective effect is so small, that this protocol cannot be considered as an antibiotherapy with its potential for associated bacterial resistance.
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